Evidence map›Paper›PMID 35721420›Full record

ArticleIJID regions2022

Clinical characteristics and outcomes of confirmed COVID-19 patients in the early months of the pandemic in Tanzania: a multicenter cohort study.

Nicholaus P Mnyambwa, Clara Lubinza, Esther Ngadaya, Mbazi Senkoro, Godfather Kimaro, Gibson B Kagaruki, Stanley Binagi, Amani Malima, Paul Kazyoba, Ndekya Oriyo and 6 more

Abstract read
In one paragraph

Article in IJID regions, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Nicholaus P MnyambwaNational Institute for Medical Research, Muhimbili Research Centre, Dar es Salaam, Tanzania.
Clara LubinzaNational Institute for Medical Research, Muhimbili Research Centre, Dar es Salaam, Tanzania.
Esther NgadayaNational Institute for Medical Research, Muhimbili Research Centre, Dar es Salaam, Tanzania.
Mbazi SenkoroNational Institute for Medical Research, Muhimbili Research Centre, Dar es Salaam, Tanzania.
Godfather KimaroNational Institute for Medical Research, Muhimbili Research Centre, Dar es Salaam, Tanzania.
Gibson B KagarukiNational Institute for Medical Research, Muhimbili Research Centre, Dar es Salaam, Tanzania.
Stanley BinagiAmana Regional Referral Hospital, Dar es Salaam, Tanzania.
Amani MalimaAmana Regional Referral Hospital, Dar es Salaam, Tanzania.
Paul KazyobaNational Institute for Medical Research, Headquarter, Dar es Salaam, Tanzania.
Ndekya OriyoNational Institute for Medical Research, Headquarter, Dar es Salaam, Tanzania.
Janneth M MghambaMinistry of Health, Community Development, Gender, Elderly and Children, Dodoma, Tanzania.
Aman FredrickNational Institute for Medical Research, Muhimbili Research Centre, Dar es Salaam, Tanzania.
Kaushik RamaiyaHindu Mandal Hospital, Dar es Salaam, Tanzania.
Alimuddin ZumlaCenter for Clinical Microbiology, Division of Infection and Immunity, University College London, Royal Free Hospital Campus, London, UK.
Shabbar JaffarLiverpool School of Tropical Medicine, Pembroke Place, Liverpool, L3 5QA, UK.
Sayoki G MfinangaNational Institute for Medical Research, Muhimbili Research Centre, Dar es Salaam, Tanzania.

Funding

Wellcome Trust
6 · The paper itself

Abstract

Background: A prospective cohort study of the clinical presentations and management outcomes of laboratory-confirmed COVID-19 patients in the early months of the pandemic was performed at two hospitals in Dar es Salaam, Tanzania. Methods: Between April 1 and May 31, 2020, laboratory-confirmed COVID-19 patients seen at two tertiary facilities were consecutively enrolled in the study and followed up for 21 days. Results: 121 COVID-19 patients were enrolled; 112 (92.6%) were admitted while nine (7.4%) were seen as outpatients. The median (IQR) age of patients was 41 (30-54) years; 72 (59.5%) were male. The median (IQR) reported days from hospital admission to recovery and to death were 10 (6-18) and 5.5 (3-9), respectively. Forty-four (36.4%) patients had at least one underlying condition. Of the 112 admissions, 17 (15.2%) went to ICU, of whom 14 (82.3%) died. At the end of follow-up, 93 (76.9%) recovered, 18 (14.9%) died, seven (5.8%) remained asymptomatic, and one (0.8%) remained ill. Conclusion: Three-quarters of all COVID-19 patients were less than 60 years, reflecting Africa's young population . High ICU admissions and mortality were observed.

Indexed as

clinical outcomeCOVID-19SARS-Cov-2

Identifiers

PMID35721420
PMCPMC8734168

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.